This section describes emerging technologies that have the potential to lead to new in vitro
test methods or in silico
approaches. These technologies include: 3-dimensional physiologically-based cell and tissue models; new types of testing platforms and detection methods, including high-throughput and high-content screening methods; and structure-activity relationship and predictive computational models. The frameworks for combining and interpreting the outputs from these different approaches are described in the final section, Integrated Testing Strategies & Risk Assessment.